Media Summary: Geoff Meacham, Citi Research head of U.S. pharmaceuticals and biotechnology, joins 'Squawk Box' to break down the quarterly ... Today's biggest winners and losers in the Evan Seigerman, BMO Capital Markets head of healthcare research, joins 'The Exchange' to discuss

Merck Pfizer Stocks Under Pressure - Detailed Analysis & Overview

Geoff Meacham, Citi Research head of U.S. pharmaceuticals and biotechnology, joins 'Squawk Box' to break down the quarterly ... Today's biggest winners and losers in the Evan Seigerman, BMO Capital Markets head of healthcare research, joins 'The Exchange' to discuss The Fast Money traders discuss biotech earnings movers and losers after the bell.

Photo Gallery

Merck, Pfizer stocks under pressure after reporting earnings
Pfizer, Merk report Q4 results: Citi's Geoff Meacham on key takeaways
Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some...
Merck stock up on Q2 earnings beat, Pfizer revenue declines on falling COVID vaccine demand
Pfizer, Merck both post earnings beats
BMO's Seigerman on Pfizer-Metsera deal: Bullish as we've waited on Pfizer's foray into obesity
Merck, Pfizer post earnings beats
Merck, Pfizer jump on earnings: 5 trades
Forget Big Pharma Stocks (Pfizer, Merck): My #1 Under the Radar Healthcare Stock to Buy Now
STOCK WARS | PFIZER VS. BRISTOL MYERS SQUIBB VS. MERCK | HEALTHCARE SECTOR | EP 13
$MRK $PFE Both positive on Earnings Merck Pfizer
Pfizer (PFE) Stock Analysis: Undervalued Opportunity or Value Trap?
Sponsored
Sponsored
View Detailed Profile
Merck, Pfizer stocks under pressure after reporting earnings

Merck, Pfizer stocks under pressure after reporting earnings

Merck

Pfizer, Merk report Q4 results: Citi's Geoff Meacham on key takeaways

Pfizer, Merk report Q4 results: Citi's Geoff Meacham on key takeaways

Geoff Meacham, Citi Research head of U.S. pharmaceuticals and biotechnology, joins 'Squawk Box' to break down the quarterly ...

Sponsored
Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some...

Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some...

Today's biggest winners and losers in the

Merck stock up on Q2 earnings beat, Pfizer revenue declines on falling COVID vaccine demand

Merck stock up on Q2 earnings beat, Pfizer revenue declines on falling COVID vaccine demand

Merck

Pfizer, Merck both post earnings beats

Pfizer, Merck both post earnings beats

"Squawk Box" reports on

Sponsored
BMO's Seigerman on Pfizer-Metsera deal: Bullish as we've waited on Pfizer's foray into obesity

BMO's Seigerman on Pfizer-Metsera deal: Bullish as we've waited on Pfizer's foray into obesity

Evan Seigerman, BMO Capital Markets head of healthcare research, joins 'The Exchange' to discuss

Merck, Pfizer post earnings beats

Merck, Pfizer post earnings beats

"Squawk Box" reports on

Merck, Pfizer jump on earnings: 5 trades

Merck, Pfizer jump on earnings: 5 trades

The Fast Money traders discuss biotech earnings movers and losers after the bell.

Forget Big Pharma Stocks (Pfizer, Merck): My #1 Under the Radar Healthcare Stock to Buy Now

Forget Big Pharma Stocks (Pfizer, Merck): My #1 Under the Radar Healthcare Stock to Buy Now

FREE REPORT: Get Steve's

STOCK WARS | PFIZER VS. BRISTOL MYERS SQUIBB VS. MERCK | HEALTHCARE SECTOR | EP 13

STOCK WARS | PFIZER VS. BRISTOL MYERS SQUIBB VS. MERCK | HEALTHCARE SECTOR | EP 13

STOCK

$MRK $PFE Both positive on Earnings Merck Pfizer

$MRK $PFE Both positive on Earnings Merck Pfizer

MRK released earnings the

Pfizer (PFE) Stock Analysis: Undervalued Opportunity or Value Trap?

Pfizer (PFE) Stock Analysis: Undervalued Opportunity or Value Trap?

Pfizer

Which is the Healthiest Investment: Merck or Pfizer | FAST Graphs

Which is the Healthiest Investment: Merck or Pfizer | FAST Graphs

Merck

Pfizer Stock VS Moderna Stock | What to Know About Pharma & Biotech Investing

Pfizer Stock VS Moderna Stock | What to Know About Pharma & Biotech Investing

Pfizer stock

Pfizer (PFE) Stock: The Ultimate Dividend Giant or a Massive Value Trap? 🚨

Pfizer (PFE) Stock: The Ultimate Dividend Giant or a Massive Value Trap? 🚨

What is happening with

RISE of PFIZER? | Is Pfizer a BUY after PILL? | PFIZER vs MERCK | Stock Analysis | News

RISE of PFIZER? | Is Pfizer a BUY after PILL? | PFIZER vs MERCK | Stock Analysis | News

Is

2025 STOCK PRICES (STOCK ANALYSIS) MERCK,PFIZER,PEPSI

2025 STOCK PRICES (STOCK ANALYSIS) MERCK,PFIZER,PEPSI

2025

If You Own Pfizer Stock - Get Ready! 🚀

If You Own Pfizer Stock - Get Ready! 🚀

Patreon Link: https://www.patreon.com/user?u=92507128 Get $25 of FREE

Pfizer’s 43B Make-or-Break Move: Massive Dividend or Giant Trap? FULL Breakdown 🔍

Pfizer’s 43B Make-or-Break Move: Massive Dividend or Giant Trap? FULL Breakdown 🔍

USStockMarket1

Pfizer Stock | The REAL Risks of Investing on Vaccine News

Pfizer Stock | The REAL Risks of Investing on Vaccine News

Pfizer stock

Related Video Content

Merck | Home information

At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we...

English Home - Merck Group information

May 21, 2026 · Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across Healthcare,...

Merck & Co. - Wikipedia information

In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and...

English Home - Merck KGaA, Darmstadt, Germany information

May 21, 2026 · Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare,...

The Merck Manuals - The Trusted Provider of Medical Information … information

The Manuals, known as the Merck Manuals in the United States and Canada and MSD Manuals outside the United States and...